Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
홍콩, June 25, 2026 (GLOBE NEWSWIRE) -- Guest Supply가 호텔 산업을 대상으로 아시아·태평양 지역에서 RODA 브랜드의 스킨케어 및 퍼스널케어 제품을 제조·유통하기 위해 RODA와 라이선스 계약을 체결했다고 오늘 발표했다. 이번 계약은 Guest Supply의 호텔용 제품 제조·유통 및 서비스 역량과 RODA의 임상...
-
LENZ Therapeutics and Arrotex Pharmaceuticals Announce Exclusive License and Commercialization Agreement for VIZZ™ in Australia and New Zealand
-
Duesseldorf, NORDRHEIN-WESTFALEN, June 19, 2026 (GLOBE NEWSWIRE) -- LOS ANGELES / DUESSELDORF — IvyBears, the new digital-first kids and family entertainment universe created by Kaan Haylaz and...
-
Lead program, MMT-205, licensed from MabTics Co., Ltd / Curacle Co., Ltd. is a potential best-in-class bispecific antibody which activates Tie2 and inhibits VEGF, in development for neovascular...
-
Los Angeles, June 17, 2026 (GLOBE NEWSWIRE) -- Applied Atomics announced today that it has entered a licensing agreement with BWX Technologies, Inc. (NYSE: BWXT) in connection with BWXT’s mPower™...
-
NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) -- Our Bond, Inc. (“Bond”) (NASDAQ: OBAI), the creator of the world’s first AI-powered Preventative Personal Security platform adopted by leading...
-
Duesseldorf, Germany, June 12, 2026 (GLOBE NEWSWIRE) -- IvyBears, the fast-growing children’s brand expanding into animated entertainment, has unveiled the official trailer for Episode 3 of its new...
-
NEW YORK, June 11, 2026 (GLOBE NEWSWIRE) -- Xcel Brands (NASDAQ: XELB), an industry-leading media and consumer products company specializing in building influencer led brands through social commerce...
-
WILMINGTON, Del., June 11, 2026 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a wireless, video and AI technology research and development company, today announced that it has entered into...
-
60 Degrees Pharma licensed FSU technology for Australian Chestnut Extract production and plans FDA discussions before refiling its NDIN.